[HTML][HTML] Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC

V Bafiti, E Thanou, S Ouzounis, A Kotsakis… - Cancers, 2024 - mdpi.com
Abstract Background and Objective: Lung cancer, the second most prevalent cancer
globally, poses significant challenges in early detection and prognostic assessment. Despite …

MALAT1 and BCYRN1 lncRNAs expression in patients with breast cancer from Northwest Iran

A Ahmadi, A Moqadami, M Khalaj-Kondori, MAH Feizi - Human Gene, 2024 - Elsevier
Introduction Abnormally expressed lncRNAs in cancer tissues can potentially play as
biomarkers for cancer diagnosis, prognosis, and treatment. This study aimed to assess the …

[HTML][HTML] Propofol orchestrates long non-coding RNAs in MCF7 cells, unraveling new avenues for breast cancer intervention

CB Avci, TG Edgunlu, T Suzek, NP Ozates… - European Journal of …, 2024 - Elsevier
Long non-coding RNAs (lncRNAs) play a dynamic role in gene expression regulation and
serve as potential therapeutic targets in breast cancer. The anticancer effect of propofol, an …

Hsa_circYARS interacts with miR-29a-3p to up-regulate IREB2 and promote laryngeal squamous cell carcinoma progression

Z Guo, Y Zhao, N Guo, M Xu, X Wang - Discover Oncology, 2024 - Springer
Objective This study was to investigate the carcinogenic capacity of circYARS in laryngeal
squamous cell carcinoma (LSCC) and to reveal its potential mechanism as a competitive …